Megan Curran, M.D.
![Megan Curran, M.D.](https://www.curejm.org/wp-content/uploads/Megan-Curran.jpg)
Video Resources
![](https://www.curejm.org/wp-content/uploads/Curejm-Resources.jpg)
At Cure JM, we want all our information to be accessible to you and your family. We have compiled all of our video resources in one place for you to view at your leisure.
What Parents Should Know About IVIg (Intra-Venous ImmunoGlobulin)
![What is IVIG?](https://www.curejm.org/wp-content/uploads/IVG-Graphic-2.jpg)
Important Information for Parents to Know About IVIg (Intra-Venous ImmunoGlobulin)
Published Research Studies and Abstracts Supported by Cure JM
![](https://www.curejm.org/wp-content/uploads/Posts-2.jpg)
There are a number of published studies about juvenile myositis. Browse this list of over 100 published research studies and abstracts.
Clinical Care Network
![](https://www.curejm.org/wp-content/uploads/53228184195_e2fca7ce8d_o.jpg)
Patients with juvenile myositis deserve the best care possible. The Cure JM Clinical Care Network links patients to top juvenile myositis physicians.
Emotional and Mental Health Information for Medical Providers
![](https://www.curejm.org/wp-content/uploads/curejm-pediatricians.jpg)
We recommend that mental health assessment and treatment options be an integral part of comprehensive care for children, adolescents, and adults with juvenile myositis.
Understanding Second-Line Treatments and Side Effects
![](https://www.curejm.org/wp-content/uploads/Understanding-Second-line-treatments-and-side-effects-2.jpg)
In this presentation, Drs. Curran and Kim explain second-line medications that should be considered after the initial treatment period with induction of treatments already discussed—either the patient cannot tolerate these medications or is still active.